CXCL3 and cervical carcinoma: Our previous study has revealed that CXCL3 acts through its receptor (CXCR2) to activate the expression of the extracellular signal-regulated kinase (ERK) signaling pathway-related genes, including ERK1/2, Bcl-2, and Bax, thereby promoting the proliferation of cervical cancer cells through the MAPK/ERK pathway [11].